# Vertex Pharmaceuticals (Europe) Ltd: insider transactions

SEC CIK 1761216. Roles and transactions as reported on Form 4. Latest Form 4 filed 2018-12-28.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [CRISPR Therapeutics AG](/companies/crsp.md) | 10% owner | 6 | 2018-12-21 | 2018-12-27 |

## Transactions: 6

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2018-12-27 | [CRISPR Therapeutics AG](/companies/crsp.md) | Purchase (P) | 27,461 | $24.9487 | $685.1k | [Form 4](/filings/0001209191-18-064322.md) |
| 2018-12-26 | [CRISPR Therapeutics AG](/companies/crsp.md) | Purchase (P) | 12,737 | $24.8942 | $317.1k | [Form 4](/filings/0001209191-18-064322.md) |
| 2018-12-24 | [CRISPR Therapeutics AG](/companies/crsp.md) | Purchase (P) | 53,655 | $24.9687 | $1.3m | [Form 4](/filings/0001209191-18-064099.md) |
| 2018-12-24 | [CRISPR Therapeutics AG](/companies/crsp.md) | Purchase (P) | 11,742 | $23.1766 | $272.1k | [Form 4](/filings/0001209191-18-064099.md) |
| 2018-12-24 | [CRISPR Therapeutics AG](/companies/crsp.md) | Purchase (P) | 2,603 | $22.9147 | $59.6k | [Form 4](/filings/0001209191-18-064099.md) |
| 2018-12-21 | [CRISPR Therapeutics AG](/companies/crsp.md) | Purchase (P) | 22,742 | $22.5784 | $513.5k | [Form 4](/filings/0001209191-18-064099.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 2, 2026, 18:19 ET. No prices; not investment advice.